Lung retransplantation in the modern era
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Chronic lung allograft dysfunction remains the leading cause of long-term morbidity and mortality for lung transplant recipients. Lung retransplantation currently represents the only therapeutic option for patients for refractory allograft dysfunction. However, debate remains regarding both the efficacy and ethicality of lung retransplantation in light of the shortage of lung allografts. The aim of this review is to discuss the available literature on lung retransplantation in the current era. Through this we hope to provide insight into ideal patient selection, donor organ selection, surgical approaches, and future considerations within the field in order to improve outcomes and best address organ utilization while a waitlist continues to exist. Lung retransplantation in select patients can offer comparable survival outcomes to primary lung transplantation. However, several risk factors including retransplantation with the first year of primary transplantation, older age, poor functional status, and ICU level requirements prior to transplantation are associated with worsened outcomes. Donor organ selection considerations are comparable to those in primary lung transplantation. However, surgical approach is often impacted by dense pleural and mediastinal adhesions in the recipient which increase the complexity of the hilar dissection. The postoperative course is often more complex for patients undergoing retransplantation compared to those undergoing primary lung transplant as well. However, pending more data on long term outcomes in lung retransplantation and the potential impact of retransplant recipients on waitlist mortality, lung retransplantation should remain in use primarily for the treatment of chronic graft dysfunction in carefully selected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Survival following second lung transplant in CF patients is lower than estimates following first transplant.”
From Cystic fibrosis survival outcomes following second lung transplant: The north American experience (2023) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although risk factors for worse survival following re-transplant have been identified, the results are often reported overall and not by underlying disease state which limits our understanding of how CF-specific factors influence mortality in this population.9”
From Cystic fibrosis survival outcomes following second lung transplant: The north American experience (2023) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329 · cited 1×
“This trend likely reflects center specific decisions to limit retransplantation due to increased surgical complexity (11).”
BackgroundChambers, D. C., Cherikh, W. S., Harhay, M. O., Hayes, D., Hsich, E., Khush, K. K., Meiser, B., Potena, L., Rossano, J. W., Toll, A. E., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.08.001 · Cited by 1,269
Chambers, D. C., Yusen, R. D., Cherikh, W. S., Goldfarb, S. B., Kucheryavaya, A. Y., Khusch, K., Levvey, B. J., Lund, L. H., Meiser, B., Rossano, J. W., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.016 · Cited by 1,045
Khush, K. K., Cherikh, W. S., Chambers, D. C., Harhay, M. O., Hayes, D., Hsich, E., Meiser, B., Potena, L., Robinson, A., Rossano, J. W., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.08.004 · Cited by 960
Development of the New Lung Allocation System in the United States
Egan, T. M., Murray, S., Bustami, R. T., Shearon, T. H., McCullough, K. P., Edwards, L. B., Coke, M. A., Garrity, E. R., Sweet, S. C., Heiney, D. A., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01276.x · Cited by 767
Liver Transplantation in the United States, 1999-2008
Thuluvath, P. J., Guidinger, M. K., Fung, J. J., Johnson, L. B., Rayhill, S. C., & Pelletier, S. J. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03037.x · Cited by 574
Restrictive allograft syndrome (RAS): A novel form of chronic lung allograft dysfunction
Sato, M., Waddell, T. K., Wagnetz, U., Roberts, H. C., Hwang, D. M., Haroon, A., Wagnetz, D., Chaparro, C., Singer, L. G., Hutcheon, M. A., et al. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.01.712 · Cited by 459
Heart-Lung Transplantation: Lessons Learned and Future Hopes
Griffith, B. P., Hardesty, R. L., Trento, A., Paradis, I. L., Duquesnoy, R. J., Zeevi, A., Dauber, J. H., Dummer, J. S., Thompson, M. E., Gryzan, S., et al. (1987) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)60157-9 · Cited by 191
Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage
Neuberger, J., & James, O. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90002-8 · Cited by 179
Ex Vivo Evaluation of Nonacceptable Donor Lungs
Wierup, P., Haraldsson, Å., Nilsson, F., Pierre, L., Scherstén, H., Silverborn, M., Sjöberg, T., Westfeldt, U., & Steen, S. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.08.015 · Cited by 168
Lung Transplantation in the United States, 1999-2008
Yusen, R. D., Shearon, T. H., Qian, Y., Kotloff, R., Barr, M. L., Sweet, S., Dyke, D. B., & Murray, S. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03055.x · Cited by 151
Lung size mismatch and primary graft dysfunction after bilateral lung transplantation
Eberlein, M., Reed, R. M., Bolukbas, S., Diamond, J. M., Wille, K. M., Orens, J. B., Brower, R. G., & Christie, J. D. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.09.030 · Cited by 130
Pulmonary Retransplantation: Predictors of Graft Function and Survival in 230 Patients
Novick, R. J., Stitt, L., Alkattan, K., Klepetko, W., Schäfers, H., Duchatelle, J. P., Khaghani, A., Hardesty, R. L., Patterson, G. A., & Yacoub, M. H. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)01191-0 · Cited by 129
Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study
Verleden, S. E., Todd, J. L., Sato, M., Palmer, S. M., Martinu, T., Pavlisko, E. N., Vos, R., Neyrinck, A., Van Raemdonck, D., Saito, T., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13281 · Cited by 123
The collaborative transplant study registry
Opelz, G., Döhler, B., Ruhenstroth, A., Cinca, S., Unterrainer, C., Stricker, L., Scherer, S., Gombos, P., Süsal, C., Daniel, V., et al. (2013) · Transplantation Reviews · doi:10.1016/j.trre.2013.01.004 · Cited by 120
Outcomes after Lung Retransplantation in the Modern Era
Kawut, S. M., Lederer, D. J., Keshavjee, S., Wilt, J. S., Daly, T., D'Ovidio, F., Sonett, J. R., Arcasoy, S. M., & Barr, M. L. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1132oc · Cited by 119 · cited 4×
“These improvements settled many concerns about fairness in organ allocation, although interestingly, they also helped patients undergoing retransplantation receive new allografts sooner (6,9,10).”
BackgroundInfluentialEberlein, M. H., Permutt, S., Chahla, M. F., Bölükbas, S., Nathan, S. D., Shlobin, O. A., Shelhamer, J. H., Reed, R. M., Pearse, D. B., Orens, J. B., et al. (2011) · CHEST Journal · doi:10.1378/chest.11-0767 · Cited by 118
Survival Determinants in Lung Transplant Patients With Chronic Allograft Dysfunction
Verleden, G. M., Vos, R., Verleden, S. E., De Wever, W., De Vleeschauwer, S. I., Willems-Widyastuti, A., Scheers, H., Dupont, L. J., Van Raemdonck, D. E., & Vanaudenaerde, B. M. (2011) · Transplantation · doi:10.1097/tp.0b013e31822bf790 · Cited by 118
Ius, F., Sommer, W., Tudorache, I., Avsar, M., Siemeni, T., Salman, J., Molitoris, U., Gras, C., Juettner, B., Puntigam, J., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.08.016 · Cited by 115 · cited 7×
“A meta-analysis of the cumulative experience points to improved survival for those with awake, bridging venovenous (VV) rather than venoarterial (VA) ECMO at 1 year (67% vs. 20%), although results continue to be limited by small sample sizes and influenced by institutional experience (21).”
MethodInfluentialProper donor selection for heart-lung transplantation
Harjula, A. L. J., Baldwin, J. C., Starnes, V. A., Stinson, E. B., Oyer, P. E., Jamieson, S. W., & Shumway, N. E. (1987) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)36159-8 · Cited by 103
Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation
Verleden, S. E., Vanaudenaerde, B. M., Emonds, M.-P., Van Raemdonck, D. E., Neyrinck, A. P., Verleden, G. M., & Vos, R. (2017) · European Respiratory Journal · doi:10.1183/13993003.01248-2017 · Cited by 100
Donor–Recipient Size Matching and Survival after Lung Transplantation. A Cohort Study
Eberlein, M., Reed, R. M., Maidaa, M., Bolukbas, S., Arnaoutakis, G. J., Orens, J. B., Brower, R. G., Merlo, C. A., & Hunsicker, L. G. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201301-008oc · Cited by 86
Lung Allocation in the United States
Eberlein, M. H., Garrity, E. R., & Orens, J. B. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.02.004 · Cited by 78
Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates
Kim, M., Townsend, K. R., Wood, I. G., Boukedes, S., Guleria, I., Gabardi, S., El-Chemaly, S., Camp, P. C., Chandraker, A. K., Milford, E. L., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2160oc · Cited by 72 · cited 1×
“However, following transplantation, patients with high pretransplant DSAs and those who develop persistent de novo DSAs in the posttransplant setting have higher rates of antibody mediated rejection, CLAD, and overall mortality (33,34).”
BackgroundAntibody-Mediated Rejection in Lung Transplantation
Kulkarni, H. S., Bemiss, B., & Hachem, R. R. (2015) · Current Transplantation Reports · doi:10.1007/s40472-015-0074-5 · Cited by 48
Two Decades of Lung Retransplantation: A Single-Center Experience
Hall, D. J., Belli, E. V., Gregg, J. A., Salgado, J. C., Baz, M. A., Staples, E. D., Beaver, T. M., & Machuca, T. N. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.09.107 · Cited by 43
Osho, A. A., Castleberry, A. W., Snyder, L. D., Palmer, S. M., Ganapathi, A. M., Hirji, S. A., Lin, S. S., Davis, R. D., & Hartwig, M. G. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.06.036 · Cited by 42 · cited 1×
“Risk factors associated with worse outcomes following retransplantation include early retransplantation within the first year, older age, female gender, 6-minute walk test less than 400 feet, donor-recipient height ratio <1, poor functional status, ICU level requirements prior to transplantation, operations performed…”
BackgroundSelf-citationComprehensive outcomes after lung retransplantation: A single‐center review
Halloran, K., Aversa, M., Tinckam, K., Martinu, T., Binnie, M., Chaparro, C., Chow, C., Waddell, T., McRae, K., Pierre, A., et al. (2018) · Clinical Transplantation · doi:10.1111/ctr.13281 · Cited by 42 · cited 3×
“Ultimately, however, similar to primary transplants, patients undergoing retransplantation typically die as a consequence of graft failure or infectious complications (23).”
BackgroundResultLung Retransplantation for Chronic Rejection: A Single-Center Experience
Roy, S. B., Panchanathan, R. S., Walia, R., Varsch, K. E., Kang, P. T., Huang, J. L., Hashimi, A. S., Mohanakumar, T., Bremner, R. M., & Smith, M. A. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.07.025 · Cited by 41
Retransplantation Outcomes at a Large Lung Transplantation Program
Ren, D., Kaleekal, T. S., Graviss, E. A., Nguyen, D. T., Sinha, N., Goodarzi, A., Agboli, I., Suarez, E. E., Loebe, M., Scheinin, S. A., et al. (2018) · Transplantation Direct · doi:10.1097/txd.0000000000000844 · Cited by 36
Kilic, A., Beaty, C. A., Merlo, C. A., Conte, J. V., & Shah, A. S. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.05.080 · Cited by 34
Outcomes and Long-term Survival After Pulmonary Retransplantation: A Single-Center Experience
Wallinder, A., Danielsson, C., Magnusson, J., Riise, G. C., & Dellgren, G. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.04.028 · Cited by 33
Gray, A., Mulvihill, M. S., & Hartwig, M. G. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.02.08 · Cited by 33
Self-citationMassard, G., Badier, M., Guillot, C., Reynaud‐Gaubert, M., Thomas, P. A., Giudicelli, R., & Noirclerc, M. (1993) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)33841-3 · Cited by 30
Massard, G., Badier, M., Guillot, C., et al. (1993) · PubMed · Cited by 26
The Optimal Procedure for Retransplantation After Single Lung Transplantation
Kon, Z. N., Bittle, G. J., Pasrija, C., Sánchez, P. G., Griffith, B. P., & Pierson, R. N. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.10.002 · Cited by 20
Technique and Outcomes of Less Invasive Lung Retransplantation
Sommer, W., Ius, F., Kühn, C., Avsar, M., Salman, J., Siemeni, T., Müller, C., Schwerk, N., Greer, M., Gottlieb, J., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001905 · Cited by 19
Donation after Brain Death versus Donation after Circulatory Death: Lung Donor Management Issues
Levvey, B. J., Levin, K., Paraskeva, M. A., Westall, G. P., & Snell, G. I. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1615820 · Cited by 18
Outcomes after Lung Retransplantation in the Modern Era
Maurer, J. (2009) · Yearbook of Pulmonary Disease · doi:10.1016/s8756-3452(08)79232-6 · Cited by 11
Revilla‐López, E., Berastegui, C., Sáez, B., López‐Meseguer, M., Monforte, V., Bravo, C., Sacanell, J., Laura, R. V., Moreno, A., & Román, A. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2018.12.018 · Cited by 9
Lung retransplantation: walking a thin line between hope and false expectations
Godinas, L., Raemdonck, D. E. V., Ceulemans, L. J., Vos, R., & Verleden, G. M. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.11.02 · Cited by 7
Survival Determinants in Lung Transplant Patients With Chronic Allograft Dysfunction
MAURER, J. R. (2012) · Yearbook of Pulmonary Disease · doi:10.1016/j.ypdi.2011.12.013 · Cited by 7
Yang, J. J., Pan, X., Fu, S., & Heng, Z. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.07.94 · Cited by 6
Eberlein, M. H., Permutt, S., Reed, R. M., Nathan, S. D., Shlobin, O. A., Bölükbas, S., Pearse, D. B., Fessler, H., Orens, J. B., & Brower, R. G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1136 · Cited by 4
Technique and Outcomes of Less Invasive Lung Retransplantation
Sommer, W., Ius, F., Kuehn, C., Avsar, M., Salman, J., Siemeni, T., Gottlieb, J., Schwerk, N., Haverich, A., Tudorache, I., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.01.296 · Cited by 4
Outcomes and Long-Term Survival after Pulmonary Retransplantation-A Single Center Experience
Wallinder, A., Magnusson, J. M., Danielsson, C., Riise, G. C., & Dellgren, G. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.01.844 · Cited by 4
Predicting Survival for Lung Retransplantation Patients at One and Five Years
Clausen, E. S., Weber, J. M., Neely, M. L., & Palmer, S. M. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.01.553 · Cited by 3
Research works printed but not linked: 1
- [1]The International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant (TTX) Registry of the International Society for Heart and Lung Transplantation: Thirty-Sixth Annual Report. J Heart Lung Transplant 2019; 38: 1015- 66. 31548031 PMC6816343
Cited by
3D bioprinting of the airways and lungs for applications in tissue engineering and in vitro models
Zhang, Y., Liu, Y., Shu, C., Shen, Y., Li, M., Ma, N., & Zhao, J. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241309183 · Cited by 32
Cystic fibrosis survival outcomes following second lung transplant: The north American experience
Alshehri, M., Ramos, K. J., Sykes, J., Ma, X., Stanojevic, S., Quon, B. S., Marshall, B. C., Cromwell, E., Ostrenga, J. S., Faro, A., et al. (2023) · Clinical Transplantation · doi:10.1111/ctr.15097 · Cited by 9
Juvet, S., Snell, G., Bos, S., Budev, M. M., Greenland, J. R., Halloran, K. M., Lindstedt, S., Snyder, L. D., Abdulqawi, R., Abedini, A., et al. (2026) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2026.02.1677 · Cited by 9
Jaing, T., Wang, Y.-L., & Chiu, C.-C. (2024) · Cancers · doi:10.3390/cancers16213715 · Cited by 6
Coster, J. N., Chan, E. G., Furukawa, M., Pilewski, J. M., Nguyen, M. H., & Sánchez, P. G. (2023) · JTCVS Techniques · doi:10.1016/j.xjtc.2023.03.017 · Cited by 6
Metadata
- Authors
- Rucker, A. J., Nellis, J. R., Klapper, J. A., & Hartwig, M. G.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Rucker, A. Justin
- Venue
- Journal of Thoracic Disease
- Publisher
- AME Publishing Company
- Published
- 2021-11
- Volume
- 13
- Issue
- 11
- Pages
- 6587-6593
- ISSN
- 2072-1439 (ISSN-L)
- 2077-6624
- PMC
- PMC8662476
- OpenAlex
- W3180867812
- Cited by
- 23
- References
- 48
- Citations by year
- 2026: 8 · 2025: 2 · 2024: 9 · 2023: 4
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Journal of Thoracic Disease (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- lung retransplantation, chronic lung allograft dysfunction, donor organ selection, patient selection, surgical approach, hilar dissection, postoperative complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.